Penumbra (PEN) announced the U.S. FDA clearance and launch of the Ruby XL System, the longest, largest and softest coil on the market. The Ruby XL System is designed to help physicians achieve more efficient embolization, potentially reducing radiation exposure, and optimizing outcomes – especially in large vessel and high-flow embolizationii
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEN:
- Penumbra: Strong Market Position and Growth Potential Drive Buy Rating
- Penumbra Amends Incorporation Certificate After Stockholder Vote
- Penumbra’s Growth Potential Boosted by STORM-PE Trial and Thunderbolt Device Innovations
- Penumbra’s Strategic Positioning and Growth Potential Justify Buy Rating
- Penumbra Inc. Earnings Call Highlights Strong U.S. Growth